Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.

Royal jelly (RJ), a creamy substance secreted by honeybees, is the exclusive diet for queen bee differentiation and life maintenance. RJ has been used in cosmetics, beverages, medicines, and supplements worldwide. However, allergy is a concerning issue for RJ, especially in atopic dermatitis (AD) an...

Full description

Bibliographic Details
Main Authors: Taketoshi Hata, Takako Furusawa-Horie, Yasuko Arai, Tomoko Takahashi, Mariko Seishima, Kenji Ichihara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0233707
id doaj-4851d8ab345a47a0b487a5d17269d29b
record_format Article
spelling doaj-4851d8ab345a47a0b487a5d17269d29b2021-03-03T21:49:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01156e023370710.1371/journal.pone.0233707Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.Taketoshi HataTakako Furusawa-HorieYasuko AraiTomoko TakahashiMariko SeishimaKenji IchiharaRoyal jelly (RJ), a creamy substance secreted by honeybees, is the exclusive diet for queen bee differentiation and life maintenance. RJ has been used in cosmetics, beverages, medicines, and supplements worldwide. However, allergy is a concerning issue for RJ, especially in atopic dermatitis (AD) and asthma patients. In some cases, allergic reactions are seen after the first intake of RJ, suggesting the existence of allergens cross-reactive with RJ. Information about the cross-reactive allergens is very important for the safe application of RJ; however, study of this cross-reactivity is quite limited. In this study, we attempted to identify allergens cross-reactive with RJ by using serum samples from 30 AD patients who had never been exposed to RJ. In an enzyme-linked immunosorbent assay (ELISA) experiment, RJ-binding IgE antibodies were detected in the serum of 10 out of 30 patients, and their antibody titers ranged from 4- to 2,048-fold dilution ratios. Additionally, 3 AD patients were determined to be positive in a skin-prick test (SPT) with an RJ solution. Significant correlations were observed between the anti-RJ antibody titer and nonspecific IgE and between the anti-RJ antibody titer and the Eczema Area and Severity Index score. We further examined the cross-reactivity between RJ and 14 typical allergens by using an ELISA-inhibition assay and demonstrated that the following 6 allergens showed cross-reactivity with RJ: the European house dust mite (HDM) (Dermatophagoides pteronyssinus), American HDM (Dermatophagoides farinae), snow crab (Chionocetes spp.), edible crab (Cancer pagurus), German cockroach (Blatella germanica), and honeybee venom (Apis mellifera). In conclusion, people with a history of allergic diseases, including AD, asthma, and allergic rhinitis, should be cautioned against consuming RJ products because of the potential for cross-reactive responses to ensure the safe and successful use of RJ supplements.https://doi.org/10.1371/journal.pone.0233707
collection DOAJ
language English
format Article
sources DOAJ
author Taketoshi Hata
Takako Furusawa-Horie
Yasuko Arai
Tomoko Takahashi
Mariko Seishima
Kenji Ichihara
spellingShingle Taketoshi Hata
Takako Furusawa-Horie
Yasuko Arai
Tomoko Takahashi
Mariko Seishima
Kenji Ichihara
Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
PLoS ONE
author_facet Taketoshi Hata
Takako Furusawa-Horie
Yasuko Arai
Tomoko Takahashi
Mariko Seishima
Kenji Ichihara
author_sort Taketoshi Hata
title Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
title_short Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
title_full Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
title_fullStr Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
title_full_unstemmed Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
title_sort studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Royal jelly (RJ), a creamy substance secreted by honeybees, is the exclusive diet for queen bee differentiation and life maintenance. RJ has been used in cosmetics, beverages, medicines, and supplements worldwide. However, allergy is a concerning issue for RJ, especially in atopic dermatitis (AD) and asthma patients. In some cases, allergic reactions are seen after the first intake of RJ, suggesting the existence of allergens cross-reactive with RJ. Information about the cross-reactive allergens is very important for the safe application of RJ; however, study of this cross-reactivity is quite limited. In this study, we attempted to identify allergens cross-reactive with RJ by using serum samples from 30 AD patients who had never been exposed to RJ. In an enzyme-linked immunosorbent assay (ELISA) experiment, RJ-binding IgE antibodies were detected in the serum of 10 out of 30 patients, and their antibody titers ranged from 4- to 2,048-fold dilution ratios. Additionally, 3 AD patients were determined to be positive in a skin-prick test (SPT) with an RJ solution. Significant correlations were observed between the anti-RJ antibody titer and nonspecific IgE and between the anti-RJ antibody titer and the Eczema Area and Severity Index score. We further examined the cross-reactivity between RJ and 14 typical allergens by using an ELISA-inhibition assay and demonstrated that the following 6 allergens showed cross-reactivity with RJ: the European house dust mite (HDM) (Dermatophagoides pteronyssinus), American HDM (Dermatophagoides farinae), snow crab (Chionocetes spp.), edible crab (Cancer pagurus), German cockroach (Blatella germanica), and honeybee venom (Apis mellifera). In conclusion, people with a history of allergic diseases, including AD, asthma, and allergic rhinitis, should be cautioned against consuming RJ products because of the potential for cross-reactive responses to ensure the safe and successful use of RJ supplements.
url https://doi.org/10.1371/journal.pone.0233707
work_keys_str_mv AT taketoshihata studiesofroyaljellyandassociatedcrossreactiveallergensinatopicdermatitispatients
AT takakofurusawahorie studiesofroyaljellyandassociatedcrossreactiveallergensinatopicdermatitispatients
AT yasukoarai studiesofroyaljellyandassociatedcrossreactiveallergensinatopicdermatitispatients
AT tomokotakahashi studiesofroyaljellyandassociatedcrossreactiveallergensinatopicdermatitispatients
AT marikoseishima studiesofroyaljellyandassociatedcrossreactiveallergensinatopicdermatitispatients
AT kenjiichihara studiesofroyaljellyandassociatedcrossreactiveallergensinatopicdermatitispatients
_version_ 1714814782528290816